Thank you for your interest 2015 ASCO Annual Meeting Conquer Cancer Foundation Patient Advocate Scholarship Program.
The scholarship application period opens on Monday, April 6 at 12:00 PM (Noon) Eastern Time and closes on Thursday, April 9 at 12:00 PM (Noon) Eastern Time. Applications will be accepted online only during the application period. For your convenience, the application questions are available in advance of the application period. Please read the Scholarship Eligibility and Criteria before applying.
All applicants will be notified of their application status on April 14.
All patient advocates awarded a scholarship must register for the ASCO Annual Meeting at the patient advocate rate of $295 by the early registration deadline of April 22, 2015.
This Patient Advocate Scholarship Program is made possible by the Conquer Cancer Foundation of the American Society of Clinical Oncology, through the generous support of Lilly, Onyx Pharmaceuticals, the Patient Access Network Foundation, Takeda Oncology, Teva Oncology, and the Conquer Cancer Foundation Mission Endowment.
For questions or additional information, please contact email@example.com or 571-483-1369.
The Conquer Cancer Foundation Patient Advocate Scholarship Program provides scholarships for patient advocates to attend ASCO-sponsored Symposia and the ASCO Annual Meeting to learn of important advances in their areas of interest. Scholarships help cover travel, hotel, and registration expenses and are based primarily on financial need, advocacy experience, and current advocacy activities and involvement.
ASCO-sponsored Symposia and the ASCO Annual Meeting give patient advocacy organizations an opportunity to promote their programs, services, and resources to the professional oncology community. These meetings also offer a venue where advocates can meet, interact, and exchange information. Advocates are encouraged to return to their organizations and their communities to share what they have learned and participate in various consumer advocacy opportunities, lending a crucial perspective and making a difference in the cancer community.